Israel - Ibrani - Ministry of Health

teva pharmaceutical indust.ltd - rosuvastatin as calcium 20 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

Israel - Ibrani - Ministry of Health

teva pharmaceutical indust.ltd - rosuvastatin as calcium 40 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

Israel - Ibrani - Ministry of Health

bayer israel ltd - levonorgestrel - התקן תוך רחמי - levonorgestrel 52 mg - levonorgestrel and estrogen - levonorgestrel and estrogen - contraception and idiopathic menorrhagia. protection from endometrial hyperplasia during estrogen replacement therapy.

Israel - Ibrani - Ministry of Health

padagis israel pharmaceuticals ltd, israel - piroxicam - ג'ל - piroxicam 0.5 %w/w - piroxicam - piroxicam - for local treatment of inflammatory conditions accompanied by pain.

Israel - Ibrani - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - piroxicam - ג'ל - piroxicam 5 mg/g - piroxicam - piroxicam - variety of conditions characterized by pain and inflammation such as osteoarthritis of superficial joints, acute musculoskeletal injuries, periarthritis, tendinitis and tenosynovitis.

Israel - Ibrani - Ministry of Health

taro international ltd, israel - piroxicam as beta-cyclodextrin - טבליה - piroxicam as beta-cyclodextrin 20 mg - piroxicam - piroxicam - piroxicam is indicated for symptomatic relief of osteoarthritis rheumatoid arthritis or ankylosing spondylitis. when an nsaid is indicated piroxicam should be considered as a second line option. the desicion to prescribe piroxocam should be based on an assesment of the individual's patient overall risk.

Israel - Ibrani - Ministry of Health

taro international ltd, israel - piroxicam as beta-cyclodextrin - אבקה מסיסה במים - piroxicam as beta-cyclodextrin 20 mg - piroxicam - piroxicam - piroxicam is indicated for symptomatic relief of osteoarthritis rheumatoid arthritis or ankylosing spondylitis. when an nsaid is indicated piroxicam should be considered as a second line option. the desicion to prescribe piroxocam should be based on an assesment of the individual's patient overall risk

Israel - Ibrani - Ministry of Health

abic marketing ltd, israel - risedronic acid as sodium - טבליה - risedronic acid as sodium 35 mg - risedronic acid - risedronic acid - treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. treatment of osteoporosis in men at high risk of fracture.

Israel - Ibrani - Ministry of Health

abic marketing ltd, israel - risedronic acid as sodium - טבליות מצופות פילם - risedronic acid as sodium 150 mg - risedronic acid - risedronic acid - treatment of postmenopausal osteoporosis.prevention of postmenopausal osteoporosis.

Israel - Ibrani - Ministry of Health

unipharm ltd, israel - risedronic acid - טבליה - risedronic acid 35 mg - risedronic acid - risedronic acid - treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. treatment of osteoporosis in men at high risk of fracture.